Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Kaye

Showing results (421-430 of 740) with videos related to

Pageof 74
Sort By:
Clinical Oncology (Royal College of Radiologists (Great Britain))|January 1, 1995
Epirubicin chemotherapy and advanced breast cancer after adjuvant CMF chemotherapyD Bissett, J Paul, G Wishart, et al.
American Journal of Infection Control|June 13, 2017
Prevalence of Clostridium difficile infection in acute care hospitals, long-term care facilities, and outpatient clinics: Is Clostridium difficile infection underdiagnosed in long-term care facility patients?Amar Krishna, Amina Pervaiz, Paul Lephart, et al.
Infection Control and Hospital Epidemiology|August 15, 2018
The epidemiological impact and significance of carbapenem resistance in Pseudomonas aeruginosa bloodstream infections: a matched case-case-control analysisTzach Aviv, Tsillia Lazarovitch, David Katz, et al.
Infection Control and Hospital Epidemiology|June 15, 2007
Underresourced hospital infection control and prevention programs: penny wise, pound foolish?Deverick J Anderson, Kathryn B Kirkland, Keith S Kaye, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 22, 2014
Bringing the "power" to Cerner's PowerChart for antimicrobial stewardshipJason M Pogue, Brian A Potoski, Michael Postelnick, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 7, 2026
Early symptom response in patients with uncomplicated urinary tract infection treated with gepotidacin or nitrofurantoin: pooled analysis from two pivotal Phase 3 studiesAmanda J Sheets, Jeremy Dennison, Jason M Pogue, et al.
Infection Control and Hospital Epidemiology|July 31, 2008
Poor functional status as a risk factor for surgical site infection due to methicillin-resistant Staphylococcus aureusDeverick J Anderson, Luke F Chen, Kenneth E Schmader, et al.
Infection Control and Hospital Epidemiology|July 11, 2007
Risk factors for Burkholderia cepacia complex bacteremia among intensive care unit patients without cystic fibrosis: a case-control studyAdam M Bressler, Keith S Kaye, John J LiPuma, et al.
Journal of Infection and Public Health|November 12, 2013
Evaluation of the potential impact of a carbapenem de-escalation program in an academic healthcare systemFarah Ahmad, Jason M Pogue, Dror Marchaim, et al.
International Journal of Antimicrobial Agents|May 29, 2018
Comparison of the composition and in vitro activity of polymyxin B productsJohn K Diep, Jenna Covelli, Rajnikant Sharma, et al.
Pageof 74

Showing results (421-430 of 740) with videos related to

Sort By:
Pageof 74
Clinical Oncology (Royal College of Radiologists (Great Britain))|January 1, 1995
Epirubicin chemotherapy and advanced breast cancer after adjuvant CMF chemotherapyD Bissett, J Paul, G Wishart, et al.
American Journal of Infection Control|June 13, 2017
Prevalence of Clostridium difficile infection in acute care hospitals, long-term care facilities, and outpatient clinics: Is Clostridium difficile infection underdiagnosed in long-term care facility patients?Amar Krishna, Amina Pervaiz, Paul Lephart, et al.
Infection Control and Hospital Epidemiology|August 15, 2018
The epidemiological impact and significance of carbapenem resistance in Pseudomonas aeruginosa bloodstream infections: a matched case-case-control analysisTzach Aviv, Tsillia Lazarovitch, David Katz, et al.
Infection Control and Hospital Epidemiology|June 15, 2007
Underresourced hospital infection control and prevention programs: penny wise, pound foolish?Deverick J Anderson, Kathryn B Kirkland, Keith S Kaye, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 22, 2014
Bringing the "power" to Cerner's PowerChart for antimicrobial stewardshipJason M Pogue, Brian A Potoski, Michael Postelnick, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 7, 2026
Early symptom response in patients with uncomplicated urinary tract infection treated with gepotidacin or nitrofurantoin: pooled analysis from two pivotal Phase 3 studiesAmanda J Sheets, Jeremy Dennison, Jason M Pogue, et al.
Infection Control and Hospital Epidemiology|July 31, 2008
Poor functional status as a risk factor for surgical site infection due to methicillin-resistant Staphylococcus aureusDeverick J Anderson, Luke F Chen, Kenneth E Schmader, et al.
Infection Control and Hospital Epidemiology|July 11, 2007
Risk factors for Burkholderia cepacia complex bacteremia among intensive care unit patients without cystic fibrosis: a case-control studyAdam M Bressler, Keith S Kaye, John J LiPuma, et al.
Journal of Infection and Public Health|November 12, 2013
Evaluation of the potential impact of a carbapenem de-escalation program in an academic healthcare systemFarah Ahmad, Jason M Pogue, Dror Marchaim, et al.
International Journal of Antimicrobial Agents|May 29, 2018
Comparison of the composition and in vitro activity of polymyxin B productsJohn K Diep, Jenna Covelli, Rajnikant Sharma, et al.
Pageof 74